The Effect Site Concentration of Remifentanil for Preventing QTc Interval Prolongation During Intubation in Normotensive and Hypertensive Patients

• Status: Completed
• Trial end date: 2014-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

To find out the effect site concentration of remifentanil for preventing QTc interval prolongation during intubation under propofol-remifentanil anesthesia in normotensive and hypertensive patients

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Severance Hospital
• Treatments: Remifentanil

Criteria

Inclusion Criteria:

• ≥ 50 years ASA class I-II female who received surgery with endotracheal intubation

Exclusion Criteria:

• emergency surgery electrocardiography abnormality diabetes mellitus end stage renal disease moderate to severe cardiac disease moderate to severe liver dysfunction